Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Health Work Programme 2011FP7 (5th year calls) Рабочая программа «Здоровье-20117РП » (5-й конкурс) Директорат «Здоровье» Генеральный директорат по науке Европейская комиссия Not legally binding: (based on draft documents) applicants must refer to final published work programme. June 2009 1 HEALTH-NCP-NET – это сеть, объединяющая Национальные контактные точки (НКТ) по приоритетному направлению «Здоровье» в Европе и контактные точки за ее пределами. Сайт Еврокомиссии по приоритетному направлению «Здоровье»: http://cordis.europa.eu/fp7/health/home_en.html Национальный информационный офис 7 РП ЕС в Беларуси: http://fp7-nip.org.by/ Руководитель офиса: Мееровская Ольга Анатольевна тел. +375 17 2867630 e-mail:[email protected] Not legally binding: (based on draft documents) applicants must refer to final published work programme. 2 ГНУ «Институт биофизики и клеточной инженерии НАН Беларуси» г. Минск, ул. Академическая, 27 e-mail: [email protected] http://ibp.org.by/ru/?page_id=229 тел. + 375 17 284 15 68 + 375 17 284 23 57 факс: + 375 17 284 23 59 НАЦИОНАЛЬНАЯ КОНТАКТНАЯ ТОЧКА 7РП ЕС ПО ПРИОРИТЕТНОМУ НАПРАВЛЕНИЮ «ЗДОРОВЬЕ» Приказом Государственного комитета по науке и технологиям от 16 марта 2007 г. № 28 «О развитии научно-технического сотрудничества с Европейским Союзом» Институт биофизики и клеточной инженерии назначен Национальной контактной точкой (НКТ) 7РП ЕС по приоритетному направлению «Здоровье». Основные направления деятельности: Распространение информации о возможностях участия белорусских ученых в проектах 7 Рамочной Программы. Консультирование действующих и потенциальных участников из Беларуси по вопросам подготовки заявок и реализации проектов. Поиск партнеров в странах ЕС для белорусских организаций, желающих присоединиться к формирующимся консорциумам, и наоборот – поиск партнеров в Беларуси по запросам организаций из ЕС. Реклама научно-технического потенциала Беларуси в странах ЕС для продвижения участия отечественных ученых в проектах 7 РП. Проведение информационных дней и семинаров. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 3 Типы программ 7РП Европейского союза • Cooperation (сотрудничество) – • Ideas (идеи) – • Реople (люди) • Capacities (cпособности) – • Joint Research Projects (совместные исслед. проекты) – • Euroatom (евроатом) Not legally binding: (based on draft documents) applicants must refer to final published work programme. 4 • • • • • • • • Приоритеты научной и научно-технической деятельности Европейского союза 1.Energy (Энергетика ) 2.Environment (including Climate Change) (Окружающая среда, включая изменения климата) 3.Food, Agriculture and Fishery, Biotechnology (Питание, сельское и рыбное хозяйство,биотехнологии) 4.Нealth(Здоровье) 5. Information and Communication Technologies (Информационные и коммуникационные технологии) 6. Nanosciences, Nanotechnologies, Materials and new Production Technologies (Нанонауки, нанотехнологии, материалы и новые производственные технологии ) 7. Socio-economic sciences and Humanities (Социальноэкономические и гуманитарные науки) 8. Transport (including Aeronautics) (Транспорт, включая аэронавтику) • 9. Security (Безопасность) По приоритетам Еврокомиссия объявляет ежегодные конкурсы Not legally binding: (based on draft documents) applicants must refer to final published work programme. 5 Схемы финансирования • Collaborative projects (совместные проекты); • Networks of excellence (сети превосходства) • Coordination and support actions (работы по координации и поддержке) • Individual projects (индивидуальные проекты) • Support for training and career development of researches (поддержка совершенствования и карьерного роста исследователей) Not legally binding: (based on draft documents) applicants must refer to final published work programme. 6 Совместные проекты Выполняются консорциумами из представителей различных стран, проекты преследуют задачи: получение новых знаний, создание новых технологий и продукции, выполняются в рамках приоритетов по различным темам, предложено 3 типа совместных проектов (малые, средние и крупные), проекты могут быть ориентированы на специальные группы, например, SME. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 7 • Сети превосходства • Поддерживают совместные программы ряда организаций (Joint Programme Activities), объединяющих свою деятельность в определенной области исследований в ходе длительной кооперации • Работы по координации и поддержке • Поддерживают деятельность по координации и поддержке научных исследований (создание сетей, обмены учеными и информацией, транснациональный доступ к инфраструктурам и исследованиям, проведение конференций) Not legally binding: (based on draft documents) applicants must refer to final published work programme. 8 • Индивидуальные проекты Осуществляются национальными или международными группами ученых по новым актуальным научным направлениям во взаимодействии с Европейским научно-исследовательским советом • Поддержка совершенствования и карьерного роста ученых Осуществляется через систему грантов им. Марии Кюри Not legally binding: (based on draft documents) applicants must refer to final published work programme. 9 Сети 7РП В рамках схемы Coordination and Support Action Еврокомиссия создала ряд сетей: • IncoNet EECA http://www.inco-eeca.net • IncoNet CA/SC - S&T International Cooperation Network for Central Asian and South Caucasus Countries http://icbss.org/index.php?option=com_content&task=view&id=2 73 • incrEAST - Information Exchange in Science and Technology between the European Research Area and Eastern European / Central Asian Countries http://www.increast.eu/ • HEALTH-NCP-NET http://www.healthncpnet.eu/jahia/Jahia/ • INCONTACT network of the INCO-NCPs http://www.ncpincontact.eu/nkswiki/index.php?title=Main_Page • HITT-CIS - Health In Times Transition: Trends in Population Health and Health Policies in CIS countries http://www.hittcis.net/ Not legally binding: (based on draft documents) applicants must refer to final published work programme. 10 ERA-NETs: • ERA.NET RUS Linking Russia to the ERA: Coordination of MS´/AC´ S&T programmes towards and with Russia http://www.era.net-rus.eu/, http://ec.europa.eu/research/iscp/pdf/russia_eranet.pdf • BS-ERA.NET Networking on science and technology in the Black Sea region http://www.bs- era.net/main/index.php?we=9bfdbe988abcff430168e60524a69c11&wchk=c 1960ad06e70dbaee80ab8641db51532, http://ec.europa.eu/research/iscp/pdf/black_sea.pdf BILATs • BILAT-RUS Enhancing the bilateral S&T Partnership with the Russian Federation http://www.bilat-rus.eu/, http://ec.europa.eu/research/iscp/pdf/russia_bilat.pdf • BILAT-UKR Enhancing the bilateral S&T Partnership with Ukraine, http://www.bilat-ukr.eu/, http://ec.europa.eu/research/iscp/pdf/ukraine.pdf Not legally binding: (based on draft documents) applicants must refer to final published work programme. 11 Participation and Success Rate in FP7 Health Research • The countries of Eastern Europe and Central Asia include: Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, the Russian Federation, Turkmenistan, Tajikistan, Ukraine and Uzbekistan. (EECAlink focuses on those underlined) • FP6: Armenia (3 - 250k€), Belarus (1 - 22k€), Ukraine (8 - 650k€), Russia (38 - €5.8Mio) • FP7: Armenia (8/2/25%), Belarus (12/2/17%) , Georgia (10/4/40%), Kazakhstan (9/2/22%), Moldova (7/3/43%), Russia (113/25/22%), • Ukraine (28/5/18%), Uzbekistan (2/1/50%) CPM Status March 2010 Not legally binding: (based on draft documents) applicants must refer to final published work programme. 12 5-ый конкурс «Здоровье» • • • Бюджет: €650m Дата объявления: 30 July 2010 Последняя дата внесения проектов : - - FP7-HEALTH-2011-single-stage, deadline: 10 Nov. 2010 (tbc) FP7-HEALTH-2011-two-stage, deadline: 13 Oct. 2010 (tbc) Not legally binding: (based on draft documents) applicants must refer to final published work programme. 13 Некоторые данные по 7РП «Здоровье» FP7 HEALTH Proposals received все страны- 21’829 , третьи страны N° of participations Grant Agreements (N° of participations EU funding 2315 405 4241 1464 591 123 327 €1’606 Mio Not legally binding: (based on draft documents) applicants must refer to final published work programme. 14 Приоритеты 5-ого конкурса • Области главных приоритетов: – the brain: neurodegenerative + lifestylerelated aspects – diabetes/obesity & lifestyle-induced conditions – antimicrobial drug resistance – emerging epidemics – health inequalities, … • Исследовательские инициативы высокой значимости: – Epigenomics – Better immunisation Not legally binding: (based on draft documents) applicants must refer to final published work programme. 15 Исследовательские инициативы высокой значимости • Major strategic investments to foster European competitive position in target areas with important economical/societal return • Programmatic approach (structuring the ERA): several research components integrated in each project, allowing synergies. • High-impact outcomes expected from coherent & ambitious strategies • Collaborative Project, but larger in size (€30 Mio) • Participation of SMEs (min. 15% of EU contribution to each project) • Governance and management will be critical. • Adapted evaluation: single-stage, with hearings Not legally binding: (based on draft documents) applicants must refer to final published work programme. 16 Тематика клинических испытаний Руководящие принципы: • Двустадийная схема внесения • Вклад EC : max. €6m/project in most cases • Читсло партнеров: в каждом случае свое (with minimum 3) • Продолжительность проектов: по усмотрению заявителей • Поощряется участие больных • Предусмотрены этические моменты (EU and national) • Возможно участие субподрядчиков Not legally binding: (based on draft documents) applicants must refer to final published work programme. 17 Тематика клинических испытаний Цель: • Translating research into clinical practice • Focus on investigator-driven CTs – relevant to public health Not legally binding: (based on draft documents) applicants must refer to final published work programme. 18 SME участие Одна из задач: облегчить и увеличить участие SME Not legally binding: (based on draft documents) applicants must refer to final published work programme. 19 Принципы международного сотрудничества • Болезни не имеют границ, поражают население богатых и бедных стран • Здоровье является политическим приоритетом для большинства стран (богатых и бедных) • Болезни богатых (рак, диабет, сердечно-сосудистые заболевания и др. ) поражают население развивающихся стран и, наоборот (малярия, туберкулез,…). • Лечение всегда универсально Not legally binding: (based on draft documents) applicants must refer to final published work programme. 20 • Все темы открыты для участников из третьих стран • Некоторые темы имеют целевое значение • Ряд тем получил название Specific International Cooperation Actions (так называемые SICAs) – Address specific issues that partner countries face or have a global character, on the basis of mutual interest and benefit Not legally binding: (based on draft documents) applicants must refer to final published work programme. 21 Ключевые факторы успеха – Предложения должны быть адресованы тематике, рабочей программе, конкретными не расплывчатыми; (not wishful thinking) – Консорциум партнеров должен быть превосходным и соответствовать задачам (select the right partners) – Предложения должны соответствовать всем требуемым критериям – Должны быть убедительными для рецензента (don’t rely on reputation) – Соответстовать основным правилам (deadlines, N° of participants, ceilings, length, ethics Not legally binding: (based on draft documents) applicants must refer to final published work programme. 22 • 3 критерия соответствия; • Science & Technology excellence Пороги 3/5 Implementation & Management 3/5 Potential Impact Overall 3/5 10/15 Not legally binding: (based on draft documents) applicants must refer to final published work programme. 23 Европейское исследовательское пространство (R&D aria) • 27 EU Member States • +7 Outermost Regions • Guadeloupe, French Guiana, Martinique and Réunion (the four French overseas departments), the Canaries (Spain), and the Azores and Madeira (Portugal) • +12 Associated Countries (the EU neighbourhood countries) • Albania, Bosnia and Herzegovina, Croatia, Iceland , Israel, Liechtenstein, FYR of Macedonia, Norway, Republic of Montenegro, Serbia, Switzerland, Turkey • +FP7 Third Countries • Other countries worldwide - can participate in FP7 • - some can receive funding (ICPC, incl. BRICS) and others only exceptionally (high-income countries) Not legally binding: (based on draft documents) applicants must refer to final published work programme. 24 Not legally binding: (based on draft documents) applicants must refer to final published work programme. 25 Участие третьих стран Not legally binding: (based on draft documents) applicants must refer to final published work programme. 26 • Участие Восточноевропейских стран (2007-2010) • Russia: 35 • Ukraine: 6 • Georgia: 5 • Rep.Moldova: 4 • Belarus: 3 • Armenia, Kazakhstan: 2 • Uzbekistan: 1 Not legally binding: (based on draft documents) applicants must refer to final published work programme. 27 Требования и финансирование • Для большинства типов проектов (CP-IPs, small/medium CP-FPs): • Минимальное число участников: 3 из MS/AS • Средний объем: большой CP-IPs – €10.7 Mio /17 partners, средний CP-FP - €3.5 Mio / 10 partners, малый CP-TP – €3.2 Mio / 8 partners • Средний показатель участия третьих стран: 30% по грантам, 8% по участникам • Specific International Cooperation Actions • Минимальное число участников: 2+2 (2 from MS/AS + 2 from ICPCs) • В среднем от третьих стран: 4 partners • Средний объем: CP-SICA - €3.4 Mio / 9 partners (5 MS/AS + 4 TC) Not legally binding: (based on draft documents) applicants must refer to final published work programme. 28 Возможности 5-ого конкурса c точки зрения сотрудничества • • • Programme-Level Cooperation with: – Russia: 1.1-3 HTP Proteomics – Brazil: 1.1.4-5 Inflammatory and Autoimmune diseases – India: 2.2.1-4 Neurodegenerative paediatric diseases – India: 2.4.1-3 Cancer from Infectious Agents – Brazil: 3.4-3 Multilateral cooperation in Public Health Specific International Cooperation Actions: – 2.1.1-4 Pop. Genetics on Cardio-Metabolic Disorders – 2.3.3-2 Control of Dengue Fever – 2.4.3-4 Obesity and/or Diabetes in Specific Populations – 3.4-1 Reproductive Health and Health Equity Other topics of particular international nature: – 2.3.3-1 Zoonotic Viruses – 2.3.3-3 Major Epidemic Outbreaks – 2.3.1-2 Evolution/transfer of AMDR – 3.3-1 Determinants of Health – 3.4-2 Research Capacity Not legally binding: (based on draft documents) applicants must refer to final published work programme. 29 Где искать информацию? • Calls for Proposals, Work Programme (Topics) http://cordis.europa.eu/fp7/health/ • National Contact Points (NCPs) - Information & support for applicants http://www.healthncpnet.eu • FP6/FP7 projects databases http://www.lifecompetence.eu/; http://www.healthcompetence.eu/ • Partner search tools http://www.smesgohealth.org/ • EU health research website http://ec.europa.eu/research/health/ Not legally binding: (based on draft documents) applicants must refer to final published work programme. 30 • Proposed topics for 2011 WP • • Activity 1 - Биотехнология, методы и технологии для медицины Not legally binding: (based on draft documents) applicants must refer to final published work programme. 31 Биотехнология, методы и технологии High-throughput research • 1.1 – • • 1.1-1 SME-targeted research for developing tools and technologies for high-throughput research. • Funding scheme: collab. project, max €6m, 2-stage, one or more proposals. • 1.1-2 Genome-based biomarkers for patient stratification and pharmacogenomic strategies. • Funding scheme: collab. project, max €6m, 2-stage, one or more proposals. • 1.1-3 High-throughput proteomics for human health and disease. (Russia) • Funding scheme: collab. project, max €3m, single-stage, one or more proposals. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 32 Биотехнология, методы и технологии • 1.2 - Detection, diagnosis and monitoring • • Closed in 2011 – 1.3 - Suitability, safety, efficacy of therapies – – Closed in 2011 Not legally binding: (based on draft documents) applicants must refer to final published work programme. 33 Биотехнология, методы и технологии • 1.4 Innovative therapeutic approaches and interventions • 1.4-1 Regenerative medicine clinical trials. • Funding scheme: collab. project, max €6m, 2-stage, one or more proposals. • 1.4-2 Tools, technologies and devices for application in regenerative medicine. • Funding scheme: collab. project, max €6m, 2-stage, one or more proposals. • 1.4-3 Development and production of new, high-affinity protein scaffolds for therapeutic use. • Funding scheme: collab. project, max €6m, 2-stage, one or more proposals. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 34 Биотехнология, методы и технологии 1.4 – Innovative therapeutic approaches and interventions – 1.4-4 High impact project immunisation. – Funding scheme: collab. project, max €30m, single-stage, max one proposal. – 1.4-5 New therapeutic approaches in chronic inflammatory and autoimmune diseases. (Brazil) – Funding scheme: collab. project, max €3m, single-stage, one or more proposals Not legally binding: (based on draft documents) applicants must refer to final published work programme. 35 • Proposed topics for 2011 WP • Activity 2 - Сквозные исследования в области здоровья (translating research for human health) Not legally binding: (based on draft documents) applicants must refer to final published work programme. 36 Сквозные исследования в области здоровья • 2.1.1 – large-scale data-gathering: • 2.1.1-1 High impact initiative on the human epigenome. • Funding scheme: collab. project, max €30m, single-stage, max one proposal. • 2.1.1-2 Proteins and their interactions in health and disease. • Funding scheme: collab. project, max €12m, 2-stage, one or more proposals. • 2.1.1-3 Large-scale genomics approaches to identify host determinants of infectious diseases. • Funding scheme: collab. project, max €12m, single-stage, max one proposal. • 2.1.1-4 Population genetic studies on cardio-metabolic disorders in EU/AC and EECA populations. • Funding scheme: Specific International Cooperation Action (SICA), collab. project, max €6m, single-stage, max one proposal. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 37 Сквозные исследования в области здоровья • 2.1 – Integrating biological data and processes • 2.1.2 – Systems biology • Closed in 2011. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 38 Сквозные исследования в области здоровья • 2.2.1 – Research on the Brain and related diseases, human development and ageing: – 2.2.1-1 Investigator-driven clinical trials for childhood-onset neurodegenerative diseases. – Funding scheme: collab. project, max €6m, 2-stage, one or more proposals. – 2.2.1-2 Understanding the role of neuroinflammation in neurodegenerative diseases. – Funding scheme: collab. project, max €12m, 2-stage, one or more proposals. – 2.2.1-3 Addictive and/or compulsive behaviour in children & adolescents: translating preclinical results into therapies – Funding scheme: collab. project, max €6m, 2-stage, one or more proposals. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 39 Сквозные исследования в области здоровья • 2.2.1 – Research on the Brain and related diseases, human development and ageing: – 2.2.1-4 Creating clinical and molecular tools for experi-mental therapy of paediatric neurodegenerative disorders causing childhood dementia in Europe and India. – Funding scheme: collab. project, max €3m, singlestage, one or more proposals. – 2.2.1-5: ERA-Net on disease-related neurosciences. – Funding scheme: CA ERA-NET, ~€2m, single-stage, max. one proposal. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 40 Сквозные исследования в области здоровья • 2.2.2 – Human development and ageing: – 2.2.2-1 Investigator-driven clinical trials for therapeutic interventions in elderly populations. – Funding scheme: collab. project, max €6m, 2stage, one or more proposals. – 2.2.2-2 Linking human development and ageing. – Funding scheme: collab. project, max €3m, 2stage, one or more proposals. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 41 Сквозные исследования в области здоровья • 2.3-1 Anti-microbial drug resistance • 2.3.1-1 Investigator-driven clinical trials of off-patent antibiotics. • Funding scheme: collab. project, max €6m, 2-stage, one or more proposals. • 2.3.1-2 Multi-disciplinary research on the evolution and transfer of antibiotic resistance. • Funding scheme: collab. project, max €12m, single-stage, max one proposal. • 2.3.1-3 Management of Gram negative multi-drug resistant infections. • Funding scheme: collab. project, max €12m, single-stage, max one proposal. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 42 Сквозные исследования в области здоровья • 2.3-1 Anti-microbial drug resistance • 2.3.1-4 Development of multi-analyte diagnostic tests. • Funding scheme: collab. project, max €3m, 2stage, one or more proposals. • 2.3.1-5 Development of tools to control microbial biofilms with relevance to clinical drug resistance. • Funding scheme: collab. project, max €3m, 2stage, one or more proposals. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 43 Сквозные исследования в области здоровья • 2.3.2 – HIV/AIDS, malaria and tuberculosis • Closed in 2011 Not legally binding: (based on draft documents) applicants must refer to final published work programme. 44 Сквозные исследования в области здоровья • 2.3.3 – Potentially new and re-emerging epidemics • 2.3.3-1 Identification of factors promoting the emergence of pathogens with human pandemic potential from pathogens with a zoonotic background and related prevention strategies. • Funding scheme: collab. project, max €12m, two-stage, max one proposal. • 2.3.3-2 Comprehensive control of Dengue fever under changing climatic conditions. (SICA: Latin Am. & Asia) • Funding scheme: collab. project, max €6m, single-stage, one or more proposals. • 2.3.3-3 Development of an evidence-based behavioural and communication package to respond to major epidemic outbreaks. • Funding scheme: collab. project, max €2m, 2-stage, one or more proposals. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 45 Сквозные исследования в области здоровья • 2.3.4 – Neglected infectious diseases • Closed in 2011 Not legally binding: (based on draft documents) applicants must refer to final published work programme. 46 Сквозные исследования в области здоровья • 2.4.1 – Cancer • 2.4.1-1 Investigator-driven, treatment trials for rare cancers. • Funding scheme: collab. project, max €6m, 2-stage, one or more proposals. • 2.4.1-2 Translational research on cancers with poor prognosis • Funding scheme: collab. project, max €3m, 2-stage, one or more proposals. • 2.4.1-3 Epidemiology and aetiology of infectionrelated cancers (in Europe & India) • Funding scheme: collab. project, max €3m, 1-stage, one or more proposals. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 47 Сквозные исследования в области здоровья • 2.4.2 – Cardiovascular disease – 2.4.2-1 Investigator-driven clinical trials for the management of cardiovascular diseases. – Funding scheme: collab. project, max €12m, 2-stage, one or more proposals. – 2.4.2-2 Evaluation and validation studies of clinically useful biomarkers in prevention and management of cardiovascular disease. – Funding scheme: collab. project, max €6m, 2-stage, one or more proposals. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 48 Сквозные исследования в области здоровья • 2.4.3 – Diabetes and obesity • 2.4.3-1 Investigator-driven clinical trials to reduce diabetes complications. • Funding scheme: collab. project, max €6m, 2-stage, one or more proposals. • 2.4.3-2 Development of novel treatment strategies based on knowledge of cellular dysfunction. • Funding scheme: collab. project, max €6m, 2-stage, one or more proposals. • 2.4.3-3 Molecular and physiological effects of lifestyle factors on diabetes/obesity. • Funding scheme: collab. project, max €6m, 2-stage, one or more proposals. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 49 Сквозные исследования в области здоровья • 2.4.3 – Diabetes and obesity • 2.4.3-4 Genetic and environmental factors in obesity and/or diabetes in specific populations. • Funding scheme: SICA (Africa, Asia, Latin America, Mediterranean countries), max €3m, 2-stage, one or more proposals. • 2.4.3-5 ERA-NET on diabetes prevention and treatment. • Funding scheme: ERA-NET CA, ~€2m, singlestage, max one project. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 50 Сквозные исследования в области здоровья • 2.4.4 – Rare diseases • Closed in 2011 • 2.4.5 – Other chronic diseases • Closed in 2011 Not legally binding: (based on draft documents) applicants must refer to final published work programme. 51 • Proposed topics for 2011 WP • Activity 3 - Оптимизация оказания лечебной помощи(Optimising the delivery of health care) Not legally binding: (based on draft documents) applicants must refer to final published work programme. 52 Оптимизация оказания лечебной помощи • 3.1 – Translating the results of clinical research outcome into clinical practice • Closed in 2011 • 3.2 – Quality, efficiency and solidarity of healthcare systems • Closed in 2011. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 53 Оптимизация оказания лечебной помощи • 3.3 – Health promotion • 3.3-1 Developing methodologies to reduce inequities in the determinants of health. • Funding scheme: collab. project, max €3m, 2-stage, one or more proposals. • 3.3-2. Analysis of integrated strategies for sustainable behaviour change. • Funding scheme: collab. project, max €3m, 2-stage, one or more proposals. • 3.3-3 Developing and implementing methods for the transfer of research into policy in the fields of health promotion and disease prevention. • Funding scheme: collab. project, max €3m, single-stage, max one proposal. • 3.3-4 A road-map for mental health research in Europe. • Funding scheme: CA, max €2m, single-stage, max one proposal. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 54 Оптимизация оказания лечебной помощи • 3.4 – International public health & health systems • 3.4-1 Development and assessment of comprehensive and integrated interventions and programmes to improve repro-ductive health and health equity. • Funding scheme: SICA (all ICPC) collab. project, max €3m, single-stage, one or more proposals. • 3.4-2 Building sustainable capacity for research for health and its social determinants in low and middle income countries. • Funding scheme: CA, max €2m, single-stage, one or more proposals. • 3.4-3 Multilateral cooperation between Europe, Africa and Latin America on public health and health services research. • Funding scheme: CA, max €2m, single-stage, max one proposal. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 55 • Proposed topics for 2011 WP • Activity 4 - Мероприятия поддержки и ответ на требования политики (support actions & response to policy need) Not legally binding: (based on draft documents) applicants must refer to final published work programme. 56 Мероприятия поддержки 4.1 – Coordination and support actions across the theme • 4.1-1 Networking of major research institutions to coordinate communication actions aimed at the media and the general public. • Funding scheme: CA, max €2m, single-stage, max one proposal. • 4.1-2 Targeting publication bias. • Funding scheme: SA, max €0.5m, single-stage, one or more proposals. • 4.1-3 Linking EU and Latin American policy-making institutions in the field of health research. • Funding scheme: CA, max €2m, single-stage, max one proposal. • 4.1-4 Organisation of supporting actions and events related to the presidency of the EU. • Funding scheme: SA, max €100,000, single-stage, one or more proposals. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 57 Мероприятия поддержки • 4.2 – Responding to EU Policy needs – 4.2-1 Investigator-driven clinical trials on off-patent medicines for children. – Funding scheme: collab. project, max €6m, single-stage, one or more proposals. – 4.2-2 Adverse drug reaction research. – Funding scheme: collab. project, max €3m, single-stage, one or more proposals. – 4.23 New methodologies for clinical trials in personalised medicine. – Funding scheme: collab. project, max €3m, single-stage, one or more proposals. Not legally binding: (based on draft documents) applicants must refer to final published work programme. 58 ГНУ «Институт биофизики и клеточной инженерии НАН Беларуси» Tel.: (+375 17) 284-17-49 Fax: (+375 17) 284-23-59 E-mail: [email protected] WWW: http://www.ipb.org.by/ - войти в раздел « общая информация», а затем – «НКТ» Not legally binding: (based on draft documents) applicants must refer to final published work programme. 59 Not legally binding: (based on draft documents) applicants must refer to final published work programme. 60 Not legally binding: (based on draft documents) applicants must refer to final published work programme. 61